Strength After Elbow Fractures in the Elderly

Launched by FRASER ORTHOPAEDIC RESEARCH SOCIETY · Nov 16, 2021

Keywords

ClinConnect Summary

This clinical trial, called "Strength After Elbow Fractures in the Elderly," is studying how well elderly patients can regain their strength and ability to perform daily activities after suffering a specific type of elbow fracture known as a Mayo type II olecranon fracture. The goal is to understand how different treatment options—both surgical (operative) and non-surgical (non-operative)—affect patients’ ability to rise from a seated position, which is an important everyday task.

To be eligible for this trial, participants need to be at least 65 years old and able to walk, either with or without assistance. However, individuals with other serious injuries, certain nerve damage, or issues that may affect their ability to participate fully, such as dementia, are not eligible. If you choose to join the study, you can expect to be closely monitored and have the chance to contribute to important research that could help improve recovery for others with similar injuries in the future. The trial is currently recruiting participants of all genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. ≥65 years of age
• • 2. Mayo type II olecranon fracture
• • 3. Ambulatory (with or without the use of walking aides)
• Exclusion Criteria:
• • 1. Additional injuries to the affected arm or contralateral arm
• • 2. Associated nerve injury
• • 3. Dementia or cognitive impairment that inhibits the collection of outcome measures
• • 4. Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.)
• • 5. Injury or previous deficit to the contralateral arm
• • 6. Currently enrolled in any other research study involving drugs or medical devices
• • 7. Open fractures
• • 8. Inability to provide informed consent